These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23761863)

  • 21. Resistance to thiostrepton, siomycin, and sporangiomycin in actinomycetes that produce them.
    Thompson J; Cundliffe E
    J Bacteriol; 1980 May; 142(2):455-61. PubMed ID: 6155371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of FOXM1 inhibition and ionizing radiation on melanoma cells.
    Lee VS; McRobb LS; Moutrie V; Santos ED; Siu TL
    Oncol Lett; 2018 Nov; 16(5):6822-6830. PubMed ID: 30405826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiostrepton and miR-216b synergistically promote osteosarcoma cell cytotoxicity and apoptosis by targeting FoxM1.
    Cai X; Xiao W; Shen J; Lian H; Lu Y; Liu X; Gu J
    Oncol Lett; 2020 Dec; 20(6):391. PubMed ID: 33193851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts.
    Wang M; Gartel AL
    Mol Cancer Ther; 2011 Dec; 10(12):2287-97. PubMed ID: 21903609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mode of FoxM1 regulation: positive auto-regulatory loop.
    Halasi M; Gartel AL
    Cell Cycle; 2009 Jun; 8(12):1966-7. PubMed ID: 19411834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells.
    Kongsema M; Wongkhieo S; Khongkow M; Lam EW; Boonnoy P; Vongsangnak W; Wong-Ekkabut J
    Oncol Rep; 2019 Sep; 42(3):953-962. PubMed ID: 31322278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.
    Maekawa A; Kohashi K; Setsu N; Kuda M; Iura K; Ishii T; Matsunobu T; Nakatsura T; Iwamoto Y; Oda Y
    Cancer Sci; 2016 Jan; 107(1):95-102. PubMed ID: 26560505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells.
    Zhang X; Cheng L; Minn K; Madan R; Godwin AK; Shridhar V; Chien J
    Oncotarget; 2014 Nov; 5(22):11365-80. PubMed ID: 25426548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of FOXM1 by thiostrepton sensitizes medulloblastoma to the effects of chemotherapy.
    Lin J; Zheng Y; Chen K; Huang Z; Wu X; Zhang N
    Oncol Rep; 2013 Oct; 30(4):1739-44. PubMed ID: 23912794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dual inhibitory effect of thiostrepton on FoxM1 and EWS/FLI1 provides a novel therapeutic option for Ewing's sarcoma.
    Sengupta A; Rahman M; Mateo-Lozano S; Tirado OM; Notario V
    Int J Oncol; 2013 Sep; 43(3):803-12. PubMed ID: 23857410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiazole antibiotic thiostrepton synergize with bortezomib to induce apoptosis in cancer cells.
    Pandit B; Gartel AL
    PLoS One; 2011 Feb; 6(2):e17110. PubMed ID: 21365012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients.
    Priller M; Pöschl J; Abrão L; von Bueren AO; Cho YJ; Rutkowski S; Kretzschmar HA; Schüller U
    Clin Cancer Res; 2011 Nov; 17(21):6791-801. PubMed ID: 21918172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressive effect of antibiotic siomycin on antibody production.
    Ueno M; Furukawa S; Abe F; Ushioda M; Fujine K; Johki S; Hatori H; Ueda H
    J Antibiot (Tokyo); 2004 Sep; 57(9):590-6. PubMed ID: 15580960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia.
    Wang JY; Jia XH; Xing HY; Li YJ; Fan WW; Li N; Xie SY
    Mol Med Rep; 2015 Jul; 12(1):1457-64. PubMed ID: 25760224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structures of siomycin-B and -C and thiostrepton-B determined by NMR spectroscopy and carbon-13 signal assignments of siomycins, thiostreptons, and thiopeptin-B.
    Tori K; Tokura K; Yoshimura Y; Terui Y; Okabe K; Otsuka H; Matsushita K; Inagaki F; Miyazawa T
    J Antibiot (Tokyo); 1981 Jan; 34(1):124-9. PubMed ID: 7251503
    [No Abstract]   [Full Text] [Related]  

  • 36. Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas.
    Maekawa A; Kohashi K; Kuda M; Iura K; Ishii T; Endo M; Nakatsura T; Iwamoto Y; Oda Y
    BMC Cancer; 2016 Jul; 16():511. PubMed ID: 27439614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A gene cloning system for the siomycin producer Streptomyces sioyaensis NRRL-B5408.
    Myronovskyy M; Ostash B; Ostash I; Fedorenko V
    Folia Microbiol (Praha); 2009; 54(2):91-6. PubMed ID: 19418244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Untying the knot of transcription factor druggability: Molecular modeling study of FOXM1 inhibitors.
    Tabatabaei-Dakhili SA; Aguayo-Ortiz R; Domínguez L; Velázquez-Martínez CA
    J Mol Graph Model; 2018 Mar; 80():197-210. PubMed ID: 29414039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition by siomycin and thiostrepton of both aminoacyl-tRNA and factor G binding to ribosomes.
    Modolell J; Cabrer B; Parmeggiani A; Vazquez D
    Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1796-800. PubMed ID: 4331558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells.
    Newick K; Cunniff B; Preston K; Held P; Arbiser J; Pass H; Mossman B; Shukla A; Heintz N
    PLoS One; 2012; 7(6):e39404. PubMed ID: 22761781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.